Reliant Pharmaceuticals Submits New Data to FDA Supporting Use of Omacor(R) (Omega-3-Acid Ethyl Esters) With a Statin ... (RedNova)
LIBERTY CORNER, N.J., Dec. 13 /PRNewswire/ -- Reliant Pharmaceuticals today announced a submission to the U.S.

Data presented to FDA panel show Taxus (Antara News)
(Full text of a statement. Contact details below.)

VIVUS Announces FDA Acceptance of EvaMist(TM) NDA Submission (FinanzNachrichten)
MOUNTAIN VIEW, Calif., Dec. 12 /PRNewswire-FirstCall/ -- VIVUS, ( Nachrichten ) Inc. , a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products addressing obesity and sexual health, today announced that the new drug application (NDA) filed by the company for EvaMist(TM) was accepted for review by the U.S. Food and Drug Administration (FDA) as a new ...